Key statistics
As of last trade Charles River Laboratories International Inc (CRL:NYQ) traded at 160.57, -29.85% below its 52-week high of 228.88, set on Jan 13, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 160.44 |
|---|---|
| High | 160.61 |
| Low | 156.58 |
| Bid | 159.13 |
| Offer | 162.00 |
| Previous close | 158.74 |
| Average volume | 1.24m |
|---|---|
| Shares outstanding | 49.22m |
| Free float | 48.72m |
| P/E (TTM) | -- |
| Market cap | 7.81bn USD |
| EPS (TTM) | -1.56 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 14:38 GMT.
More ▼
Press releases
- Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
- Charles River Enters Manufacturing Collaboration with Gazi University
- Charles River Laboratories Provides Business Updates
- Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan
- Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
- Charles River Laboratories to Present at Evercore Healthcare Conference
- Charles River Laboratories to Present at Jefferies Global Healthcare Conference
More ▼
